Estudios originales

Asociación de los genotipos de IGF-1 e IGF-2 con la fuerza muscular respiratoria en individuos con EPOC: estudio transversal

Back to article
Characteristics of the studied individuals with chronic obstructive pulmonary disease.
VariablesN= 61
Age (years)67.3 ± 7.6
Male, n (%)33 (54%)
BMI (Kg/m2)26.9 ± 5.4
FVC % predicted83.4 ± 20.9
FEV1 % predicted49.2 ± 15.2
GOLD % (I, II, III, IV)1/27/27/6
MIP (cmH2O)75.9 ± 26.9
MEP (cmH2O)107.9 ± 38.0
SNP IGF-1 a
AA, n (%)3 (5%)
AG, n (%)24 (43%)
GG, n (%)29 (52%)
SNP IGF-2 b
CC, n (%)12 (23%)
CG, n (%)18 (34%)
GG, n (%)23 (43%)
Vitamin D (ng/ml)26.9 ± 11.9
SOD (U/mgHb)45.3 ± 13.9
CAT (U/mgHb)49.8 ± 11.2
TNF-α (pg/dl)0.19 ± 1.2
IL-6 (pg/dl)2.6 ± 2.7

BMI, Body mass index. CAT, Catalase. FEV1, Forced expiratory volume in one second. FVC, Forced vital capacity. GOLD, Global Initiative for Chronic Obstructive Lung Disease. IGF-1, Insulin growth factor-1. IGF-2, Insulin growth factor-2. IL-6, Interleukin six. MEP, Maximal expiratory pressure. MIP, Maximal inspiratory pressure. SNP, Single nucleotide polymorphism. SOD, superoxide dismutase. TNF-α, Tumor necrosis factor-alpha.

a analysis run with 56 patients and b analysis run with 53 patients.

Source: Prepared by the authors based on the study’s results.